19
Aspen Pharmacare Holdings, based in South Africa, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ESTROGENS, CONJUGATED SYNTHETIC B, with a corresponding application number 21443.
Regulatory Information DISCN
With a dosage strength 1.25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2004-05-10
18
Aspen Pharmacare Holdings, based in South Africa, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ESTROGENS, CONJUGATED SYNTHETIC B, with a corresponding application number 21443.
Regulatory Information DISCN
With a dosage strength 0.45MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2004-12-20
17
Aspen Pharmacare Holdings, based in South Africa, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ESTROGENS, CONJUGATED SYNTHETIC B, with a corresponding application number 21443.
Regulatory Information DISCN
With a dosage strength 0.9MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2007-04-27
16
Aspen Pharmacare Holdings, based in South Africa, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ESTROGENS, CONJUGATED SYNTHETIC B, with a corresponding application number 21443.
Regulatory Information DISCN
With a dosage strength 0.625MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2004-05-10
15
Aspen Pharmacare Holdings, based in South Africa, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ESTROGENS, CONJUGATED SYNTHETIC B, with a corresponding application number 21443.
Regulatory Information DISCN
With a dosage strength 0.3MG
Dosage Form Route TABLET; ORAL
Reference Listed Drug No
Approved since 2004-12-20